相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease
Anna Vilalta et al.
FEBS JOURNAL (2018)
Tauopathies: Mechanisms and Therapeutic Strategies
Chen-Chen Tan et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Microglia in Alzheimer's disease
David V. Hansen et al.
JOURNAL OF CELL BIOLOGY (2018)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Complement in the pathogenesis of Alzheimer's disease
B. Paul Morgan
SEMINARS IN IMMUNOPATHOLOGY (2018)
Innate Immunity and Neurodegeneration
Larisa I. Labzin et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1
Jenny U. Johansson et al.
ALZHEIMERS & DEMENTIA (2018)
High complement levels in astrocyte-derived exosomes of Alzheimer disease
Edward J. Goetzl et al.
ANNALS OF NEUROLOGY (2018)
Recent advances in inflammasome biology
David E. Place et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response
Teng Jiang et al.
INFLAMMATION (2018)
Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation
Antonia Gutierrez et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function
Qingwen Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2
Athena Sudom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Wilbur M. Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
Li Zhong et al.
MOLECULAR NEURODEGENERATION (2018)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
C. Y. Daniel Lee et al.
NEURON (2018)
Local apoptotic-like mechanisms underlie complement mediated synaptic pruning
Balazs A. Gyorffy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Li Du et al.
MOLECULAR NEUROBIOLOGY (2017)
A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease
Matthew Barron et al.
EXPERIMENTAL GERONTOLOGY (2017)
Conditional eQTL analysis reveals allelic heterogeneity of gene expression
Rick Jansen et al.
HUMAN MOLECULAR GENETICS (2017)
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio et al.
IMMUNITY (2017)
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Susanne Krasemann et al.
IMMUNITY (2017)
Inflammasome activation and assembly at a glance
Ankit Malik et al.
JOURNAL OF CELL SCIENCE (2017)
TREM2-Ligand Interactions in Health and Disease
Daniel L. Kober et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
New concepts on the therapeutic control of complement anaphylatoxin receptors
Owen A. Hawksworth et al.
MOLECULAR IMMUNOLOGY (2017)
Complement in clinical medicine: Clinical trials, case reports and therapy monitoring
Daniel Ricklin et al.
MOLECULAR IMMUNOLOGY (2017)
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
Shane M. Bemiller et al.
MOLECULAR NEURODEGENERATION (2017)
TREM2 in Neurodegenerative Diseases
Taylor R. Jay et al.
MOLECULAR NEURODEGENERATION (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
Microglia emerge as central players in brain disease
Michael W. Salter et al.
NATURE MEDICINE (2017)
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Thais F. Galatro et al.
NATURE NEUROSCIENCE (2017)
ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157
Dominik Feuerbach et al.
NEUROSCIENCE LETTERS (2017)
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
Cheryl E. G. Leyns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Qiaoqiao Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TREM2/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway
Li Zhong et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Deaths from Alzheimer's Disease - United States, 1999-2014
Christopher A. Taylor et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
The worldwide costs of dementia 2015 and comparisons with 2010
Anders Wimo et al.
ALZHEIMERS & DEMENTIA (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Other ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant
Peter Thornton et al.
EMBO MOLECULAR MEDICINE (2017)
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
Kai Schlepckow et al.
EMBO MOLECULAR MEDICINE (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease
Tyler K. Ulland et al.
CELL (2017)
Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis
Tobias Zrzavy et al.
BRAIN (2017)
Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
C. Dempsey et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Signalig pathways regulation neuron-glia interaction and their implication in Alzheimer's disease
Hong Lian et al.
JOURNAL OF NEUROCHEMISTRY (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
Claudio Villegas-Llerena et al.
CURRENT OPINION IN NEUROBIOLOGY (2016)
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2016)
Properdin: a tightly regulated critical inflammatory modulator
Adam Z. Blatt et al.
IMMUNOLOGICAL REVIEWS (2016)
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Yaming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Taylor R. Jay et al.
JOURNAL OF NEUROSCIENCE (2016)
TREM2/DAP12 Signal Elicits Proinflammatory Response in Microglia and Exacerbates Neuropathic Pain
Masaaki Kobayashi et al.
JOURNAL OF NEUROSCIENCE (2016)
The road less traveled: Start-ups invest in novel approaches against neurodegeneration
Shraddha Chakradhar
NATURE MEDICINE (2016)
Complement in disease: a defence system turning offensive
Daniel Ricklin et al.
NATURE REVIEWS NEPHROLOGY (2016)
A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese
Teng Jiang et al.
NEUROBIOLOGY OF AGING (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review
Martina Finetti et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
How neuroinflammation contributes to neurodegeneration
Richard M. Ransohoff
SCIENCE (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models
Michael J. D. Daniels et al.
NATURE COMMUNICATIONS (2016)
Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
Daniel L. Kober et al.
ELIFE (2016)
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Keren Zhou et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function
Maria I. Fonseca et al.
PLOS ONE (2016)
A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome
Neetu Srivastava et al.
JCI INSIGHT (2016)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
Dimitrios C. Mastellos et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response
Li Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
Taylor R. Jay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline
Qiaoqiao Shi et al.
JOURNAL OF NEUROSCIENCE (2015)
Genetics ignite focus on microglial inflammation in Alzheimer's disease
Manasi Malik et al.
MOLECULAR NEURODEGENERATION (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
The case for rejecting the amyloid cascade hypothesis
Karl Herrup
NATURE NEUROSCIENCE (2015)
Do glia drive synaptic and cognitive impairment in disease?
Won-Suk Chung et al.
NATURE NEUROSCIENCE (2015)
Alzheimer's disease is associated with low density of the long CR1 isoform
Rachid Mahmoudi et al.
NEUROBIOLOGY OF AGING (2015)
Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus
Ji-Seon Park et al.
TRAFFIC (2015)
TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices
Lih-Fen Lue et al.
BRAIN PATHOLOGY (2015)
Neuroinflammation in Alzheimer's disease
Fengjin Zhang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Coding variants in TREM2 increase risk for Alzheimer's disease
Sheng Chih Jin et al.
HUMAN MOLECULAR GENETICS (2014)
Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury
Juan Pablo de Rivero Vaccari et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Jason D. Ulrich et al.
MOLECULAR NEURODEGENERATION (2014)
Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway
R. Killick et al.
MOLECULAR PSYCHIATRY (2014)
Microglial phagocytosis of live neurons
Guy C. Brown et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Inflammasomes in the CNS
John G. Walsh et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Heterozygous TREM2 mutations in frontotemporal dementia
Barbara Borroni et al.
NEUROBIOLOGY OF AGING (2014)
Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease
Teng Jiang et al.
NEUROPSYCHOPHARMACOLOGY (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Animal Models of the Sporadic Form of Alzheimer's Disease: Focus on the Disease and Not Just the Lesions
Khalid Iqbal et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese
Meng-Shan Tan et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology
Grietje Krabbe et al.
PLOS ONE (2013)
The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
Alexander H. Stephan et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 35 (2012)
Complement receptor 1 (CR1) and Alzheimer's disease
Helen Crehan et al.
IMMUNOBIOLOGY (2012)
Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite
Kenneth J. Katschke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study
David H. Cribbs et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism
Lili-Naz Hazrati et al.
NEUROBIOLOGY OF AGING (2012)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice
Sheri L. Bonar et al.
PLOS ONE (2012)
Animal Models of Alzheimer Disease
Frank M. LaFerla et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer's Disease Model
Masashi Kitazawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Complement in the brain
Robert Veerhuis et al.
MOLECULAR IMMUNOLOGY (2011)
C1-Inhibitor: More Than a Serine Protease Inhibitor
Sacha Zeerleder
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)
Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma
An-Qiang Zhang et al.
CRITICAL CARE (2011)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
TREM2-and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
Qisheng Peng et al.
SCIENCE SIGNALING (2010)
Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Juana M. Sanz et al.
JOURNAL OF IMMUNOLOGY (2009)
Interleukin-1β enhances nucleotide-induced and α-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y2 receptor
Qiongman Kong et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Structural Insights into Formation of an Active Signaling Complex between Rac and Phospholipase C Gamma 2
Tom D. Bunney et al.
MOLECULAR CELL (2009)
Complement Receptor 1: Disease associations and therapeutic implications
Rohan Khera et al.
MOLECULAR IMMUNOLOGY (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Interleukin-1β up-regulates TACE to enhance α-cleavage of APP in neurons:: resulting decrease in Aβ production
Yuriko Tachida et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Complement C3 deficiency leads to accelerated amyloid β plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice
Marcel Maier et al.
JOURNAL OF NEUROSCIENCE (2008)
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle et al.
NATURE IMMUNOLOGY (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly
J-C Lambert et al.
MOLECULAR PSYCHIATRY (2007)
Chronic interleukin-1β expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration
Solomon S. Shaftel et al.
JOURNAL OF NEUROSCIENCE (2007)
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Solomon S. Shaftel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
Dailing Mao et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12
Jessica A. Hamerman et al.
JOURNAL OF IMMUNOLOGY (2006)
Src homology 2 domain-containing inositol-5-phosphatase 1 (SITP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism
HZ An et al.
BLOOD (2005)
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2
K Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
S100ß protein:: The preoperative new clinical indicator of brain damage in patients with fulminant hepatic failure
S Shiotani et al.
TRANSPLANTATION PROCEEDINGS (2004)
Targeting anticomplement agents
RAG Smith
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
T Wyss-Coray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
In-vivo measurement of activated microglia in dementia
A Cagnin et al.
LANCET (2001)
CNS manifestations of Nasu-Hakola disease - A frontal dementia with bone cysts
J Paloneva et al.
NEUROLOGY (2001)
Altered cytokine production in mice lacking P2X7 receptors
M Solle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Complement components of the innate immune system in health and disease in the CNS
P Gasque et al.
IMMUNOPHARMACOLOGY (2000)
Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
A Bouchon et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
